
Exciting news to report: Pittsburgh is the U.S. site for a clinical trial with a gene-independent, cone sparing therapy for retinitis pigmentosa. SparingVision, a French company developing therapies for ocular […]
Exciting news to report: Pittsburgh is the U.S. site for a clinical trial with a gene-independent, cone sparing therapy for retinitis pigmentosa. SparingVision, a French company developing therapies for ocular […]
The Department of Ophthalmology at the University of Pittsburgh School of Medicine was the first in the world to use optogenetics to restore vision. The Eye & Ear Foundation’s August […]